<DOC>
	<DOCNO>NCT03063892</DOCNO>
	<brief_summary>Tranexamic Acid ( TXA ) antifibrolytic medication use total hip knee arthroplasty reduce need intraoperative postoperative blood transfusion . Limited research available use hip fracture patient . We hypothesize use TXA preoperatively , perioperatively , postoperatively decrease blood loss need blood transfusion postoperatively .</brief_summary>
	<brief_title>Effect Tranexamic Acid ( TXA ) Reduction Postoperative Blood Transfusion</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Over age 60 year Hip fracture require surgical intervention Signs consent agree participate Under age 60 Does sign consent refuse participation Known hypersensitivity tranexamic acid Multiple acute fracture Creatinine clearance &lt; 30 History seizure Active hormone therapy History coagulation abnormality History deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) within last year history recurrent DVT/PE Myocardial infarction ( MI ) and/or stent within past year History intracranial hemorrhage Acquired defective color vision Patients admit directly nurse unit surgery without stay Emergency Center Patients sustain fracture hospitalize ProMedica Toledo Hospital</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>